Skip to main content
IDEXX LABORATORIES INC /DE logo

IDEXX LABORATORIES INC /DE — Investor Relations & Filings

Ticker · IDXX ISIN · US45168D1046 LEI · OGMTXK0LUU1HKV2P0J84 US Professional, scientific and technical activities
Filings indexed 1,395 across all filing types
Latest filing 2010-10-22 Interim / Quarterly Rep…
Country US United States of America
Listing US IDXX

About IDEXX LABORATORIES INC /DE

https://www.idexx.com/

IDEXX Laboratories, Inc. is a global leader in diagnostics and software for the veterinary, livestock, and water testing markets. The company develops, manufactures, and distributes a broad range of products and services aimed at enhancing the health and well-being of pets, people, and livestock. Core offerings include in-clinic point-of-care diagnostic instruments and tests, a global network of reference laboratories providing advanced testing services, and practice management software solutions for veterinarians. These integrated solutions provide veterinarians with actionable insights to deliver advanced medical care and improve practice efficiency.

Recent filings

Filing Released Lang Actions
10-Q Filing
Interim / Quarterly Report Q3 2010
2010-10-22 English
8-K Filing
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated October 22, 2010, announcing financial results for the quarter ended September 30, 2010. It specifically references a press release titled 'IDEXX Laboratories Announces Third Quarter Results' as Exhibit 99.1. The content is a current report providing initial financial results for a quarter, which aligns with an Earnings Release. The document length is 3064 characters, which is relatively short and consistent with a Form 8-K earnings announcement rather than a full interim report. Therefore, the document is best classified as an Earnings Release (ER).
2010-10-22 English
8-K Filing
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated October 1, 2010, by IDEXX Laboratories, Inc. The content focuses on the announcement of new executive employment agreements with key officers, detailing terms related to change in control, payments, benefits, and equity awards. There is no financial statement or comprehensive financial data presented. The primary subject is the appointment and contractual terms of senior management executives, which aligns with announcements about changes in board or senior management. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 9489 characters, which is sufficient to contain substantive information rather than a brief announcement or certification. Hence, the classification is MANG with high confidence.
2010-10-07 English
4 Filing
Director's Dealing
2010-10-06 English
4 Filing
Director's Dealing
2010-09-08 English
3 Filing
Director's Dealing
2010-09-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.